Willow Biosciences Inc (WLLW) — Cash Flow Quality Index
Latest as of September 2021:
-1.10x
Willow Biosciences Inc (WLLW) has a Cash Flow Quality Index of -1.10x as of September 2021. Operating cash flow of CA$-4.22 Million is below net income of CA$3.84 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Willow Biosciences Inc strategic investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
-1.10x
Operating CF / Net Income
Operating Cash Flow
CA$-4.22 Million
CAD
Net Income
CA$3.84 Million
CAD
Data as of
Sep 2021
Most recent filing
Annual Cash Flow Quality Index for Willow Biosciences Inc (None–None)
Year-by-year earnings quality comparison for Willow Biosciences Inc. For live market cap and the full company financial profile, see market cap of Willow Biosciences Inc.
| Year | Quality Index | Operating CF (CAD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.